NCT05431569 2022-06-24
A Phase IIa Study to Evaluate the Efficacy and Safety of 6MW3211 in Patients With Advanced Lung Cancer
Mabwell (Shanghai) Bioscience Co., Ltd.
Phase 2 Unknown
Mabwell (Shanghai) Bioscience Co., Ltd.
Sichuan J.Z. Bio-chemical Science and Technology Development Co., Ltd